AstraZeneca starts final-stage tests on severe asthma drug – Reuters


Reuters UK

AstraZeneca starts final-stage tests on severe asthma drug
Reuters
Several firms are racing to develop injectable biotech asthma drugs for patients with severe disease who do not respond well to traditional inhalers, in pursuit of a new market worth a possible $7.5 billion a year. (Reporting by Ben Hirschler, Editing
AstraZeneca Starts Phase III Trial For Asthma Drug TralokinumabLondon South East
AstraZeneca Starts Late-stage Study Of Tralokinumab – Quick FactsRTT News

all 4 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.